🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Hongye Zou

University of California, San Francisco

ORCID: 0000-0002-3377-2336
Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases”.

RORγ is a context-specific master regulator of cholesterol biosynthesis and an emerging therapeutic target in cancer and autoimmune diseases

Biochemical Pharmacology(2021)10.1016/j.bcp.2021.114725
N/A
0DataRank · unranked
32 citations

Nianxin Yang, Xiong Zhang, Hong-Wu Chen, Hongye Zou

A mitochondria-targeting lipid–small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model

Acta Pharmaceutica Sinica B(2022)10.1016/j.apsb.2022.04.005
N/A
0DataRank · unranked
40 citations

Kai Lin, Mythili Ramachandran, Longmeng Li, Hongye Zou, Huzhi Zheng +3 more

Nuclear receptor RORγ inverse agonists/antagonists display tissue- and gene-context selectivity through distinct activities in altering chromatin accessibility and master regulator SREBP2 occupancy

Pharmacological Research(2022)10.1016/j.phrs.2022.106324
N/A
0DataRank · unranked
11 citations

Yatian Yang, Zhenrui Shi, Xuesong Wu, Ruiwu Liu, Ai‐Ming Yu +2 more

Natural compounds ursolic acid and digoxin exhibit inhibitory activities to cancer cells in RORγ-dependent and -independent manner

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1146741
N/A
0DataRank · unranked
9 citations

Yatian Yang, Hong-Wu Chen, Hongye Zou

Effective therapeutic targeting of tumor lineage plasticity in neuroendocrine prostate cancer by BRD4 inhibitors

Acta Pharmaceutica Sinica B(2025)10.1016/j.apsb.2025.01.007
N/A
0DataRank · unranked
12 citations

Yatian Yang, Hongye Zou, Yang Yang, Xingling Zheng, Eva Corey +6 more

Circadian regulator REV-ERBα is a master regulator of tumor lineage plasticity and an effective therapeutic target

Proceedings of the National Academy of Sciences(2025)10.1073/pnas.2513468122
N/A
0DataRank · unranked
0 citations

Yatian Yang, Hongye Zou, Demin Cai, Eva Corey, Amina Zoubeidi +5 more